Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/11844835

J. Clin. Oncol. 2002 Feb 15 20 4 1094-104

Download in:

View as

Triples

General Info

PMID
11844835